Severna Park, Maryland-based mobile sleep apnea-focused company Appian Medical has raised $580,000 from angel investors to conduct validation studies and apply for FDA 510(k) clearance for its app.
Appian CEO Michael Thomas told MobiHealthNews they are also starting talks with investors to raise their series A funding round. Thomas was formerly the CEO of asthma monitoring company iSonea.
Appian...
iSonea, the Maryland-based startup working on smartphone-based asthma monitoring, says it will launch its AirSonea connected hardware device in Australia prior to launching in the US.
The company's AirSonea product, which builds on the company's previous device, the Wheezometer, uses a proprietary sensing method the company calls Acoustic Respiratory Monitoring to monitor an asthma patient's...
Asthmapolis. Asthma Journal. AsthmaMD. GlaxoSmithKline's MyAsthma. AsthmaSense and AirSonea, both from iSonea. T-Haler. CitiSense. WeatherMD. iBiomed. Healthanywhere. SMS-based Asthma Signals.
Those are just the asthma-related mobile apps and wireless devices MobiHealthNews has written about. Check Google Play and you'll find nearly 250 Android apps for learning about, treating, tracking and...
BetterDoctor's iPhone App
In recent weeks a number of digital health startups have announced rounds of funding totaling some $26 million. MobiHealthNews has previously covered the venture capital Agile Health, iSonea, and Sherpaa raised in recent days. Here's a quick round-up of a few other digital health investments.
Aberdare Ventures and the West Health Investment Fund announced investments in...
iSonea's AsthmaSense App
Medical technology company iSonea has raised $1.05 million in funding from Australian businessman Bruce Mathieson, who now owns about 15 percent of the company.
iSonea's CEO Michael Thomas explained that the funding would help the company build more of its medical devices' functionality into the smartphone platform: "iSonea is committed to developing innovative, non-...
Maryland-based asthma device company, iSonea, makers of the Wheezometer device, recently offered up its first smartphone app, AsthmaSense for iPhone, iPad and Android users. The first iteration of AsthmaSense includes journaling features, medication and testing alert reminders, emergency services contact information, and the ability to share data with caregivers and providers.
Future versions of...
iSonea showed off its wares at HIMSS in the Qualcomm Life booth. The Asthma Sense iPhone app pictured is not yet available in the AppStore.
iSonea, makers of the WheezoMeter, has begun recruiting for a post-market study of its asthma monitoring device for children under the age of 12 years old. The company aims to determine the device's ability to accurately assess wheeze rate in a group of...
iSonea's Wheezometer
Annapolis, Maryland-based asthma monitoring technology company iSonea has inked a deal with Qualcomm Life, a subsidiary of Qualcomm, to combine iSonea's proprietary Acoustic Respiratory Monitoring (ARM) devices and forthcoming mobile health asthma management offerings with Qualcomm's recently launched 2net platform.
The deal will enable users of iSonea's asthma monitoring...
